Review Article
Next Generation Cancer Protection: The Bivalent HPV Vaccine for Females
Table 1
HPV genotype distribution among women with increasingly severe cervical abnormalities.
| | Normal women [62] | Women with LSIL [58] | Women with HSIL [59] | Women with squamous cell cervical carcinoma [60] | Women with adeno- or adenosquamous carcinoma of the cervix [60, 61] |
| | HPV 16 | 1.8% | 27% | 45% | 62% | 39%–50% | | HPV 18 | 0.7% | 9% | 7% | 8% | 32% | | HPV 31 | 0.7% | 12% | 9% | 4% | 1%-2% | | HPV 33 | 0.5% | 8% | 7% | 4% | 1%–3% | | HPV 45 | 0.5% | 5% | 2% | 5% | 12% |
|
|
